RNA cancer vaccines are at the forefront of next-generation cancer immunotherapy, showcasing significant potential.
How continent is navigating decades-old obstacles to build robust vaccine industry ANALYSIS | The African Union has embarked ...
AIM Vaccine Co., Ltd. (06660.HK), a leading PRC vaccine company, published an announcement on March 23, 2025, the company's independently developed mRNA shingles vaccine has recently received clinical ...
EVM14 received FDA clearance for clinical trials, marking Everest Medicines’ first in-house developed therapeutic to reach ...
SHANGHAI, China I March 23, 2025 I Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, ...
Researchers have identified antibodies that could lead to a broadly protective norovirus vaccine and new treatment options.
The EU is introducing new regulations (EDIRPA and EDIP) to structure military procurement through pooled orders coordinated by the ...
First and only immunotherapy to show meaningful overall survival benefit in a Phase 2 trial in patients with advanced ovarian cancer Initiation ...
US FDA clears Everest Medicines’ IND application for tumour-associated antigen vaccine, EVM14: Shanghai, China Tuesday, March 25, 2025, 15:00 Hrs [IST] Everest Medicines, a biop ...
Initiated Phase 1 clinical trial evaluating its second-generation oral norovirus vaccine constructs with topline data expected as early as ...
Creative Diagnostics, a global provider of reagents and analytical services, has released its innovative Gene Copy Number ...